{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1HrPDtJbwj\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/23568\/\">2001\u5e742\u670816\u65e5\u306e\u52d5\u7269\u5065\u5eb7\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/23568\/embed\/#?secret=1HrPDtJbwj\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for February 16, 2001&#8221; &#8212; Brakke Consulting Website\" data-secret=\"1HrPDtJbwj\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"**************************************************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for February 16, 2001 Copyright &copy; Brakke Consulting, Inc. **************************************************************** Company Earnings Releases &gt;&nbsp; Novartis reported results for the year 2000.&nbsp; Animal Health sales were CHF 1,083 million ($672 million), an increase of 17% over 1999 (9% increase in local currencies).&nbsp; Interceptor and Fortekor posted solid growth, and the farm animal business grew overall driven by Tiamulin sales.&nbsp; The acquisitions of Vericore, the Biostar product range, and Cobequid also made important contributions to sales.&nbsp; 2000 Operating income for the Animal Health group were CHF 179 million ($111 million), a decrease of 17% from 1999.&nbsp; The decline was attributed to one-time acquisition and separation costs and product-mix changes.&nbsp; Increase in research and development increased from 7% to 8% of sales. (company website) &gt;&nbsp; Eli Lilly reported that sales for animal health division Elanco in the fourth quarter 2000 were $197.3 million, an increase of 3% compared with the fourth quarter of 1999.&nbsp; For the full year of 2000, animal health sales increased 6% to $668.5 million. Excluding the effect of exchange rates, sales grew by 7% for the quarter and 10% for the year. (company website) &gt;&nbsp; Pharmacia reported sales for the animal health division were $118 million in the fourth quarter of 2000, a decrease of 9% from the comparable period inView Full Post;"}